Combination therapy including dupilumab, omalizumab, and mycophenolate mofetil for refractory bullous pemphigoid.
Saved in:
| Title: | Combination therapy including dupilumab, omalizumab, and mycophenolate mofetil for refractory bullous pemphigoid. |
|---|---|
| Authors: | Ratnarajah K; Division of Dermatology, McGill University Health Center, Montreal, Quebec, Canada., Arès S; Faculty of Medicine, Université de Sherbrooke, Sherbrooke, Quebec, Canada., Kechichian E; Division of Dermatology, Université de Sherbrooke, Sherbrooke, Quebec, Canada., Fernandes CL; Division of Dermatology, Université de Sherbrooke, Sherbrooke, Quebec, Canada. |
| Source: | JAAD case reports [JAAD Case Rep] 2025 Aug 19; Vol. 65, pp. 201-205. Date of Electronic Publication: 2025 Aug 19 (Print Publication: 2025). |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101665210 Publication Model: eCollection Cited Medium: Print ISSN: 2352-5126 (Print) Linking ISSN: 23525126 NLM ISO Abbreviation: JAAD Case Rep Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2352-5126 |
|---|---|
| DOI: | 10.1016/j.jdcr.2025.08.001 |
